New horizons in the pathogenesis, assessment and management of movement disorders
Age and Aging, 08/21/2012
Duncan GW et al. – Great progress has been made in understanding the molecular and cellular processes that drive the pathological changes in these conditions, as have advances in neuroimaging and preclinical drug discovery programmes. Unfortunately, this is yet to translate into disease–modifying therapies for these progressive disorders. Advances have been also made in non–pharmacological interventions such as tailored physiotherapy and speech therapy programmes. The important contribution of palliative care has been recognised and increasingly incorporated into the multidisciplinary approach.